22:19 , Oct 11, 2018 |  BC Innovations  |  Translation in Brief

Public funding highlights: 3Q18

Public funding highlights: 3Q18 Selected developments and initiatives in 3Q18 from major sources of public funding including NIH, the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR)...
16:15 , Oct 4, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer; breast cancer; ovarian cancer Cell culture and mouse studies suggest niclosamide could help treat p53-mutant colorectal, ovarian and breast cancers. High throughput screening of a library of 1,600 approved compounds in p53-wild type...
03:01 , Sep 1, 2018 |  BioCentury  |  Politics, Policy & Law

A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
19:04 , Jun 6, 2018 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: Gene profiling A mutation in CAMK2A could help predict the risk of a previously undescribed neurodevelopmental disorder characterized by growth delay, frequent seizures and severe cognitive dysfunction. Genomic profiling of two children with the disease...
18:25 , Jun 1, 2018 |  BC Week In Review  |  Financial News

Lion raises $20M in series A

Cell therapy company Lion TCR Pte. Ltd. (Singapore) raised $20 million on May 27 in a series A round from undisclosed existing investors and new investors, including Yashang Capital and Westlake Ventures Capital. The company is...
18:53 , May 29, 2018 |  BC Extra  |  Financial News

Lion raises $20M series A

Lion TCR Pte. Ltd. (Singapore) raised $20 million in a series A round from undisclosed existing investors and new investors, including Yashang Capital and Westlake Ventures Capital. The company is developing LioCyx, an autologous T cell...
18:05 , May 25, 2018 |  BioCentury  |  Finance

HKEX’s on-demand experts

The Hong Kong stock exchange is well aware its investor base is new to the high-risk, high-reward nature of its newly hatched biotech chapter and has no qualms about admitting its own lack of expertise....
16:42 , Apr 5, 2018 |  BC Innovations  |  Finance

Public funding highlights

Public funding highlights Selected developments and initiatives in 1Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of...
21:12 , Feb 22, 2018 |  BC Innovations  |  Finance

Bigger BRAIN Initiative

The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is preparing to push projects in three areas past the pilot phase with $169 million in new NIH grants announced in 4Q17. The aim is to...
23:07 , Feb 8, 2018 |  BC Innovations  |  Finance

External rethink

As the industry seeks to develop new ways to access external innovation, companies are re-evaluating the value of public-private partnerships, and increasingly turning to other companies for research partnerships in lieu of broad deals with...